Ceramide/Sphingomyelin Rheostat Regulated by Sphingomyelin Synthases and Chronic Diseases in Murine Models

키워드

참고문헌 (144)

1. Hannun YA, "Principles of bioactive lipid signalling : lessons from sphingolipids", Nat Rev Mol Cell Biol, 9, pp.139~150 (2008)
2. Hannun YA, "Sphingolipids and their metabolism in physiology and disease", Nat Rev Mol Cell Biol, 19, pp.175~191 (2018)
3. Tafesse FG, "The multigenic sphingomyelin synthase family", J Biol Chem, 281, pp.29421~29425 (2006)
4. Taniguchi M, "The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders", Biochim Biophys Acta, 1841, pp.692~703 (2014)
5. Simons K, "Lipid rafts and signal transduction", Nat Rev Mol Cell Biol, 1, pp.31~39 (2000)
6. Alonso A, "The physical properties of ceramides in membranes", Annu Rev Biophys, 47, pp.633~654 (2018)
7. Stancevic B, "Ceramide-rich platforms in transmembrane signaling", FEBS Lett, 584, pp.1728~1740 (2010)
8. Stith JL, "Advances in determining signaling mechanisms of ceramide and role in disease", J Lipid Res, 60, pp.913~918 (2019)
9. Kazuyuki Kitatani, "Role of Sphingolipids and Metabolizing Enzymes in Hematological Malignancies", Molecules and Cells, 38(6), pp.482~495 (2015), 한국분자세포생물학회
10. Hannun YA, "Many ceramides", J Biol Chem, 286, pp.27855~27862 (2011)
11. Dickson RC, "Sphingolipid functions in Saccharomyces cerevisiae : comparison to mammals", Annu Rev Biochem, 67, pp.27~48 (1998)
12. Pewzner-Jung Y, "When do Lasses(longevity assurance genes)become CerS(ceramide synthases)? : Insights into the regulation of ceramide synthesis", J Biol Chem, 281, pp.25001~25005 (2006)
13. Mandon EC, "Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase, and sphinganine N-acyltransferase in mouse liver", J Biol Chem, 267, pp.11144~11148 (1992)
14. Kitatani K, "The sphingolipid salvage pathway in ceramide metabolism and signaling", Cell Signal, 20, pp.1010~1018 (2008)
15. Sribney M, "The enzymatic synthesis of sphingomyelin", J Biol Chem, 233, pp.1315~1322 (1958)
16. Yamaoka S, "Expression cloning of a human cDNA restoring sphingomyelin synthesis and cell growth in sphingomyelin synthase-defective lymphoid cells", J Biol Chem, 279, pp.18688~18693 (2004)
17. Huitema K, "Identification of a family of animal sphingomyelin synthases", EMBO J, 23, pp.33~44 (2004)
18. Vacaru AM, "Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis in the ER", J Cell Biol, 185, pp.1013~1027 (2009)
19. Ternes P, "Sphingomyelin synthase SMS2 displays dual activity as ceramide phosphoethanolamine synthase", J Lipid Res, 50, pp.2270~2277 (2009)
20. Ding T, "All members in the sphingomyelin synthase gene family have ceramide phosphoethanolamine synthase activity", J Lipid Res, 56, pp.537~545 (2015)
21. Hanada K, "Molecular machinery for non-vesicular trafficking of ceramide", Nature, 426, pp.803~809 (2003)
22. Yeang C, "The domain responsible for sphingomyelin synthase(SMS)activity", Biochim Biophys Acta, 1781, pp.610~617 (2008)
23. Yeang C, "Subcellular targeting domains of sphingomyelin synthase 1 and 2", Nutr Metab(Lond), 8, pp.89~ (2011)
24. Mullen TD, "Ceramide synthases at the centre of sphingolipid metabolism and biology", Biochem J, 441, pp.789~802 (2012)
25. Tafesse FG, "Sphingomyelin synthase-related protein SMSr is a suppressor of ceramide-induced mitochondrial apoptosis", J Cell Sci, 127, pp.445~454 (2014)
26. Meruelo AD, "Identifying polymer-forming SAM domains", Proteins, 74, pp.1~5 (2009)
27. Hayashi Y, "Complex formation of sphingomyelin synthase 1 with glucosylceramide synthase increases sphingomyelin and decreases glucosylceramide levels", J Biol Chem, 293, pp.17505~17522 (2018)
28. Deevska GM, "Novel interconnections in lipid metabolism revealed by overexpression of sphingomyelin synthase-1", J Biol Chem, 292, pp.5110~5122 (2017)
29. Ogiso H, "Analysis of lipid-composition changes in plasma membrane microdomains", J Lipid Res, 56, pp.1594~1605 (2015)
30. Hayashi Y, "Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion", J Biol Chem, 289, pp.30842~30856 (2014)
31. Anand AR, "HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1", Blood, 114, pp.3588~3600 (2009)
32. Liu Y, "HIV infection of T cells : actin-in and actin-out", Sci Signal, 2, pp.pe23~ (2009)
33. Cabukusta B, "ER residency of the ceramide phosphoethanolamine synthase SMSr relies on homotypic oligomerization mediated by its SAM domain", Sci Rep, 7, pp.41290~ (2017)
34. Murakami C, "Diacylglycerol kinase δ and sphingomyelin synthase-related protein functionally interact via their sterile α motif domains", J Biol Chem, 295, pp.2932~2947 (2020)
35. Ebinu JO, "RasGRP, a Ras guanyl nucleotide-releasing protein with calcium-and diacylglycerol-binding motifs", Science, 280, pp.1082~1086 (1998)
36. Galluzzi L, "Molecular mechanisms of cell death : recommendations of the Nomenclature Committee on Cell Death 2018", Cell Death Differ, 25, pp.486~541 (2018)
37. Itoh M, "Possible role of ceramide as an indicator of chemoresistance : decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia", Clin Cancer Res, 9, pp.415~423 (2003)
38. Albi E, "Chromatin sphingomyelin changes in cell proliferation and", or apoptosis induced by ciprofibrate, 2003, pp.196, 354~361
39. Watanabe M, "Increase of nuclear ceramide through caspase-3-dependent regulation of the"sphingomyelin cycle"in Fas-induced apoptosis", Cancer Res, 64, pp.1000~1007 (2004)
40. Taguchi Y, "Interleukin-2-induced survival of natural killer(NK)cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase", Blood, 104, pp.3285~3293 (2004)
41. Albi E, "Nuclear sphingomyelin pathway in serum deprivation-induced apoptosis of embryonic hippocampal cells", J Cell Physiol, 206, pp.189~195 (2006)
42. Albi E, "The nuclear ceramide", diacylglycerol balance depends on the physiological state of thyroid cells and changes during UV-C radiation-induced apoptosis, 2008, pp.478, 52~58
43. Luberto C, "Differential effects of sphingomyelin hydrolysis and resynthesis on the activation of NF-kappa B in normal and SV40-transformed human fibroblasts", J Biol Chem, 275, pp.14760~14766 (2000)
44. Meng A, "Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells", Exp Cell Res, 292, pp.385~392 (2004)
45. -decan-8-yl dithiocarbonate(D609)chemical stability and cytotoxicity against U937 leukemia cells, "J Pharmacol Exp Ther", 2004, 1051~1059
46. Chan SY, "Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species", Exp Mol Pathol, 82, pp.1~11 (2007)
47. Yang Z, "Identification of mouse sphingomyelin synthase 1 as a suppressor of Bax-mediated cell death in yeast", FEMS Yeast Res, 6, pp.751~762 (2006)
48. Separovic D, "Sphingomyelin synthase 1 suppresses ceramide production and apoptosis post-photodamage", Biochem Biophys Res Commun, 358, pp.196~202 (2007)
49. Separovic D, "Suppression of sphingomyelin synthase 1 by small interference RNA is associated with enhanced ceramide production and apoptosis after photodamage", Exp Cell Res, 314, pp.1860~1868 (2008)
50. Lafont E, "Ordering of ceramide formation and caspase-9 activation in CD95L-induced Jurkat leukemia T cell apoptosis", Biochim Biophys Acta, 1821, pp.684~693 (2012)
51. Tu R, "Inhibition of sphingomyelin synthase 1 affects ceramide accumulation and hydrogen peroxide-induced apoptosis in Neuro-2a cells", Neuroreport, 27, pp.967~973 (2016)
52. Zhang P, "Sphingomyelin synthase 2 promotes H2O2-induced endothelial dysfunction by activating the Wnt", β-catenin signaling pathway, 2018, pp.42, 3344~3354
53. Dai Q, "Mitochondrial ceramide increases in UV-irradiated HeLa cells and is mainly derived from hydrolysis of sphingomyelin", Oncogene, 23, pp.3650~3658 (2004)
54. Takahashi E, "Effects of ceramide inhibition on radiation-induced apoptosis in human leukemia MOLT-4 cells", J Radiat Res(Tokyo), 47, pp.19~25 (2006)
55. Miyaji M, "Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis", J Exp Med, 202, pp.249~259 (2005)
56. Marsden VS, "Control of apoptosis in the immune system : Bcl-2, BH3-only proteins and more", Annu Rev Immunol, 21, pp.71~105 (2003)
57. Van der Luit AH, "Resistance to alkyl-lysophospholipid-induced apoptosis due to downregulated sphingomyelin synthase 1 expression with consequent sphingomyelin-and cholesterol-deficiency in lipid rafts", Biochem J, 401, pp.541~549 (2007)
58. Alderliesten MC, "Phosphoinositide phosphatase SHIP-1 regulates apoptosis induced by edelfosine, Fas ligation and DNA damage in mouse lymphoma cells", Biochem J, 440, pp.127~135 (2011)
59. van Blitterswijk WJ, "Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion", Lipids, 22, pp.820~823 (1987)
60. Ruiter GA, "Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt", PKB survival pathway, 2003, pp.14, 167~173
61. van Blitterswijk WJ, "A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C", Lipids, 22, pp.842~846 (1987)
62. Luo S, "Sphingomyelin synthase 2 overexpression promotes cisplatin-induced apoptosis of HepG2 cells", Oncol Lett, 15, pp.483~488 (2018)
63. Chipuk JE, "Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis", Science, 303, pp.1010~1014 (2004)
64. Kondo K, "Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma", Int J Cancer, 118, pp.230~242 (2006)
65. Bialik S, "Autophagy-dependent cell death - where, how and why a cell eats itself to death", J Cell Sci, 131, pp.jcs215152~ (2018)
66. Dany M, "Ceramide induced mitophagy and tumor suppression", Biochim Biophys Acta, 1853, pp.2834~2845 (2015)
67. Taniguchi M, "Regulation of autophagy and its associated cell death by"sphingolipid rheostat" : reciprocal role of ceramide and sphingosine 1-phosphate in the mammalian target of rapamycin pathway", J Biol Chem, 287, pp.39898~39910 (2012)
68. Gulbins A, "Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramide", Mol Psychiatry, 23, pp.2324~2346 (2018)
69. Barceló-Coblijn G, "Sphingomyelin and sphingomyelin synthase(SMS)in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy", Proc Natl Acad Sci U S A, 108, pp.19569~19574 (2011)
70. Lou B, "2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity", J Biol Chem, 293, pp.18328~18336 (2018)
71. Terés S, "2-Hydroxyoleate, a nontoxic membrane binding anticancer drug, induces glioma cell differentiation and autophagy", Proc Natl Acad Sci U S A, 109, pp.8489~8494 (2012)
72. Brady RO, "The metabolism of sphingomyelin. II. Evidence of an enzymatic deficiency in Niemann-Pick diseae", Proc Natl Acad Sci U S A, 55, pp.366~369 (1966)
73. Gabandé-Rodríguez E, "High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A", Cell Death Differ, 21, pp.864~875 (2014)
74. Corcelle-Termeau E, "Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closure", Autophagy, 12, pp.833~849 (2016)
75. Zhang Y, "Plasma membrane changes during programmed cell deaths", Cell Res, 28, pp.9~21 (2018)
76. Linkermann A, "Necroptosis", N Engl J Med, 370, pp.455~465 (2014)
77. Nganga R, "Receptor-interacting Ser", Thr kinase 1(RIPK1)and myosin IIA-dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis, 2019, pp.294, 502~519
78. Zhang X, "Ceramide nanoliposomes as a MLKL-dependent, necroptosis-inducing, chemotherapeutic reagent in ovarian cancer", Mol Cancer Ther, 17, pp.50~59 (2018)
79. Zhang X, "Regulation of necroptosis by phospholipids and sphingolipids", Cells, 9, pp.627~ (2020)
80. Zhu Y, "Angiotensin II triggers RIPK3-MLKL-mediated necroptosis by activating the Fas", FasL signaling pathway in renal tubular cells, 2020, pp.15, e0228385~
81. Lu Z, "Ophiopogonin D' induces RIPK1-dependent necroptosis in androgen-dependent LNCaP prostate cancer cells", Int J Oncol, 56, pp.439~447 (2020)
82. Genard G, "Proton irradiation orchestrates macrophage reprogramming through NFκB signaling", Cell Death Dis, 9, pp.728~ (2018)
83. Milhas D, "The tricyclodecan-9-yl-xanthogenate D609 triggers ceramide increase and enhances FasL-induced caspase-dependent and-independent cell death in T lymphocytes", Int J Mol Sci, 13, pp.8834~8852 (2012)
84. Sawai H, "Differential changes in sphingolipids between TNF-induced necroptosis and apoptosis in U937 cells and necroptosis-resistant sublines", Leuk Res, 39, pp.964~970 (2015)
85. Shakor AB, "Sphingomyelin synthase 1-generated sphingomyelin plays an important role in transferrin trafficking and cell proliferation", J Biol Chem, 286, pp.36053~36062 (2011)
86. Tafesse FG, "Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells", J Biol Chem, 282, pp.17537~17547 (2007)
87. Burns TA, "Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene", J Lipid Res, 54, pp.794~805 (2013)
88. Moorthi S, "Bcr-Abl regulation of sphingomyelin synthase 1 reveals a novel oncogenic-driven mechanism of protein up-regulation", FASEB J, 32, pp.4270~4283 (2018)
89. Wesley UV, "Sphingomyelin synthase 1 regulates Neuro-2a cell proliferation and cell cycle progression through modulation of p27 expression and Akt signaling", Mol Neurobiol, 51, pp.1530~1541 (2015)
90. Asano S, "Regulation of cell migration by sphingomyelin synthases : sphingomyelin in lipid rafts decreases responsiveness to signaling by the CXCL12", CXCR4 pathway, 2012, pp.32, 3242~3252
91. Jin ZX, "Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1(SMS1)-knockdown T cells", Int Immunol, 20, pp.1427~1437 (2008)
92. Sancho D, "CD69 is an immunoregulatory molecule induced following activation", Trends Immunol, 26, pp.136~140 (2005)
93. Hailemariam TK, "Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation", Arterioscler Thromb Vasc Biol, 28, pp.1519~1526 (2008)
94. Taniguchi M, "Deficiency of sphingomyelin synthase 2 prolongs survival by the inhibition of lymphoma infiltration through ICAM-1 reduction", FASEB J, 34, pp.3838~3854 (2020)
95. Bickert A, "Functional characterization of enzymes catalyzing ceramide phosphoethanolamine biosynthesis in mice", J Lipid Res, 56, pp.821~835 (2015)
96. Taniguchi M, "Sphingomyelin generated by sphingomyelin synthase 1 is involved in attachment and infection with Japanese encephalitis virus", Sci Rep, 6, pp.37829~ (2016)
97. Ogiso H, "Comparative Analysis of Biological Sphingolipids with Glycerophospholipids and Diacylglycerol by LC-MS", MS, 2014, pp.4, 98~114
98. Li Z, "Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice", Arterioscler Thromb Vasc Biol, 32, pp.1577~1584 (2012)
99. Liu J, "Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice", Arterioscler Thromb Vasc Biol, 29, pp.850~856 (2009)
100. Sakamoto H, "Possible roles of long-chain sphingomyelines and sphingomyelin synthase 2 in mouse macrophage inflammatory response", Biochem Biophys Res Commun, 482, pp.202~207 (2017)
101. Li Z, "Reducing plasma membrane sphingomyelin increases insulin sensitivity", Mol Cell Biol, 31, pp.4205~4218 (2011)
102. Mitsutake S, "Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes", J Biol Chem, 286, pp.28544~28555 (2011)
103. Li Y, "Sphingomyelin synthase 2 activity and liver steatosis : an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression", Arterioscler Thromb Vasc Biol, 33, pp.1513~1520 (2013)
104. Yano M, "Increased oxidative stress impairs adipose tissue function in sphingomyelin synthase 1 null mice", PLoS One, 8, pp.e61380~ (2013)
105. Yano M, "Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice", J Biol Chem, 286, pp.3992~4002 (2011)
106. Wittmann A, "Sphingomyelin synthase 1 is essential for male fertility in mice", PLoS One, 11, pp.e0164298~ (2016)
107. Xue J, "Sphingomyelin synthase 2 inhibition ameliorates cerebral ischemic reperfusion injury through reducing the recruitment of toll-like receptor 4 to lipid rafts", J Am Heart Assoc, 8, pp.e012885~ (2019)
108. Sugimoto M, "Imaging mass spectrometry reveals acyl-chain-and region-specific sphingolipid metabolism in the kidneys of sphingomyelin synthase 2-deficient mice", PLoS One, 11, pp.e0152191~ (2016)
109. Lu MH, "Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice", J Physiol, 590, pp.4029~4044 (2012)
110. Wu M, "Regulation of membrane KCNQ1", KCNE1 channel density by sphingomyelin synthase 1, 2016, pp.311, C15~
111. Kasahara K, "Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts", Blood, 122, pp.3340~3348 (2013)
112. Mital P, "The blood-testis and blood-epididymis barriers are more than just their tight junctions", Biol Reprod, 84, pp.851~858 (2011)
113. Dong L, "CD4+ T-cell dysfunctions through the impaired lipid rafts ameliorate concanavalin A-induced hepatitis in sphingomyelin synthase 1-knockout mice", Int Immunol, 24, pp.327~337 (2012)
114. Toshima K, "Plasma membrane sphingomyelin modulates thymocyte development by inhibiting TCR-induced apoptosis", Int Immunol, 31, pp.211~223 (2019)
115. Wang C, "Sphingomyelin synthase 1 enhances BCR signaling to promote lupus-like autoimmune response", EBioMedicine, 45, pp.578~587 (2019)
116. Liu J, "Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice", Circ Res, 105, pp.295~303 (2009)
117. Fan Y, "Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis", Arterioscler Thromb Vasc Biol, 30, pp.2114~2120 (2010)
118. Jeong T, "Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase", J Clin Invest, 101, pp.905~912 (1998)
119. Wang X, "Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice", Lipids Health Dis, 10, pp.7~ (2011)
120. Zhao YR, "Sphingomyelin synthase 2 over-expression induces expression of aortic inflammatory biomarkers and decreases circulating EPCs in ApoE KO mice", Life Sci, 90, pp.867~873 (2012)
121. Gowda S, "Sphingomyelin synthase 2(SMS2)deficiency attenuates LPS-induced lung injury", Am J Physiol Lung Cell Mol Physiol, 300, pp.L430~L440 (2011)
122. Ohnishi T, "Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer", FASEB J, 31, pp.3816~3830 (2017)
123. Walther M, "Galectin-3 is upregulated in microglial cells in response to ischemic brain lesions, but not to facial nerve axotomy", J Neurosci Res, 61, pp.430~435 (2000)
124. Burguillos MA, "Microglia-secreted galectin-3 acts as a Toll-like receptor 4 ligand and contributes to microglial activation", Cell Reports, 10, pp.1626~1638 (2015)
125. Ohtani R, "Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia", Brain Res, 1023, pp.31~40 (2004)
126. Hanamatsu H, "Multiple roles of Sms2 in white and brown adipose tissues from diet-induced obese mice", J Metabolic Synd, 7, pp.1000241~ (2018)
127. Gupta G, "Airway resistance caused by sphingomyelin synthase 2 insufficiency in response to cigarette smoke", Am J Respir Cell Mol Biol, 62, pp.342~353 (2020)
128. Imokawa G, "Stratum corneum lipids serve as a bound-water modulator", J Invest Dermatol, 96, pp.845~851 (1991)
129. Imokawa G, "Decreased level of ceramides in stratum corneum of atopic dermatitis : an etiologic factor in atopic dry skin?", J Invest Dermatol, 96, pp.523~526 (1991)
130. Li Q, "The role of ceramides in skin homeostasis and inflammatory skin diseases", J Dermatol Sci, 97, pp.2~8 (2020)
131. Nomoto K, "Epidermal permeability barrier function and sphingolipid content in the skin of sphingomyelin synthase 2 deficient mice", Exp Dermatol, 27, pp.827~832 (2018)
132. Fernández-García P, "The opposing contribution of SMS1 and SMS2 to glioma progression and their value in the therapeutic response to 2OHOA", Cancers(Basel), 11, pp.88~ (2019)
133. Zhang Y, "The effect of sphingomyelin synthase 2(SMS2)deficiency on the expression of drug transporters in mouse brain", Biochem Pharmacol, 82, pp.287~294 (2011)
134. Takeshita H, "Actin organization associated with the expression of multidrug resistant phenotype in osteosarcoma cells and the effect of actin depolymerization on drug resistance", Cancer Lett, 126, pp.75~81 (1998)
135. Luciani F, "P-glycoprotein-actin association through ERM family proteins : a role in P-glycoprotein function in human cells of lymphoid origin", Blood, 99, pp.641~648 (2002)
136. Wang M, "Stressful learning paradigm precludes manifestation of cognitive ability in sphingomyelin synthase-2 knockout mice", Behav Brain Res, 319, pp.25~30 (2017)
137. Wang L, "Prenatal alcohol exposure inducing the apoptosis of mossy cells in hippocampus of SMS2-", -mice, 2015, pp.40, 975~982
138. isoxazole-3-amine derivatives as highly selective and orally efficacious human sphingomyelin synthase 2 inhibitors that reduce chronic inflammation in db, "db Mice", J Med Chem, 61, pp.8241~8254 (2018)
139. Li Y, "Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor", Eur J Med Chem, 163, pp.864~882 (2019)
140. Othman MA, "Malabaricone C as natural sphingomyelin synthase inhibitor against diet-induced obesity and its lipid metabolism in mice", ACS Med Chem Lett, 10, pp.1154~1158 (2019)
141. Matsumoto G, "Deficiency of sphingomyelin synthase 1 but not sphingomyelin synthase 2 reduces bone formation due to impaired osteoblast differentiation", Mol Med, 25, pp.56~ (2019)
142. Yoshikawa Y, "Knockdown of sphingomyelin synthase 2 inhibits osteoclastogenesis by decreasing RANKL expression in mouse primary osteoblasts", Biomed Res(Aligarh), 40, pp.189~196 (2019)
143. Takahashi N, "Osteoblastic cells are involved in osteoclast formation", Endocrinology, 123, pp.2600~2602 (1988)
144. Pekkinen M, "Osteoporosis and skeletal dysplasia caused by pathogenic variants in SGMS2", JCI Insight, 4, pp.e126180~ (2019)

관련 논문AI추천